Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $5.85B.
ENTERPRISE VALUE (EV)
$5.85B
Immunovant, Inc.
Market Cap
$6.75B
Enterprise Value (EV)
$5.85B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Immunovant, Inc. (IMVT) | $6.75B | $5.85B |
| GRAIL Inc. (GRAL)vs › | $6.83B | $6.87B |
| Chemed Corporation (CHE)vs › | $6.68B | $6.96B |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.54B | $7.48B |
| Alkermes plc (ALKS)vs › | $7.08B | $8.14B |
| Lantheus Holdings, Inc. (LNTH)vs › | $6.53B | $6.56B |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.52B | $9.18B |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.30B | $9.37B |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $6.16B | $6.09B |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $6.11B | $6.23B |
Market Cap
$6.75B
Total Debt
$0.00
Cash
$902.11M
Enterprise Value
$5.85B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
